Search

Your search keyword '"Tripathi, Ashish"' showing total 1 results
Start Over Author "Tripathi, Ashish" Region japan
1 results on '"Tripathi, Ashish"'

1. Immunogen Collaborates with Takeda to Develop and Commercialise Elahere® in Japan.

Author

Tripathi, Ashish

Subjects
EXCLUSIVE contracts, OVARIAN cancer, LICENSE agreements, CANCER patients, FOLIC acid
Abstract

In a bid to bolster its oncology pipeline, Takeda has entered into an exclusive license agreement with ImmunoGen. Through the deal, which is worth up to US$34 M, Takeda will gain Japan rights to Elahere® (mirvetuximab soravtansine-gynx) for the treatment of platinum-resistant ovarian cancer patients. Interestingly, the deal was announced three months after ImmunoGen disclosed its Phase III MIRASOL confirmatory trial results, evaluating the safety and efficacy of Elahere® in patients with folate receptor alpha-positive platinum-resistant ovarian cancer. [ABSTRACT FROM AUTHOR]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results